Literature DB >> 1380262

Identification of broadly reactive continuous antigenic determinants of simian immunodeficiency virus glycoproteins.

M A Miller1, M Murphey-Corb, R C Montelaro.   

Abstract

The env polyprotein sequences of several simian immunodeficiency virus (SIV) isolates were analyzed using computer algorithms designed to predict immunologically reactive protein segments. Peptides corresponding to predicted epitopes were synthesized and employed in peptide enzyme-linked immunosorbent assay (ELISA) screening of serum panels from experimentally infected macaques, as well as naturally infected, asymptomatic mangabeys and African green monkeys. Several of the peptides are recognized by a high percentage of antisera from each panel of monkeys indicating that they represent group-specific antigenic determinants of SIV. Several type-specific determinants also were identified. These peptides may be a useful tool for studying the kinetics of SIV glycoprotein-specific immune responses produced by infected and vaccine-protected monkeys at the epitope level.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1380262     DOI: 10.1089/aid.1992.8.1153

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  6 in total

1.  Shortening of the symptom-free period in rhesus macaques is associated with decreasing nonsynonymous variation in the env variable regions of simian immunodeficiency virus SIVsm during passage.

Authors:  P J Valli; V V Lukashov; J L Heeney; J Goudsmit
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

2.  Structured-tree topology and adaptive evolution of the simian immunodeficiency virus SIVsm envelope during serial passage in rhesus macaques according to likelihood mapping and quartet puzzling.

Authors:  P J Valli; J Goudsmit
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Induction of antibody-mediated neutralization in SIVmac239 by a naturally acquired V3 mutation.

Authors:  Seth A Faith; Yingyun Wu; David Kuhrt; Jonathan D Steckbeck; Jodi K Craigo; Janice E Clements; Kelly Stefano Cole
Journal:  Virology       Date:  2010-02-11       Impact factor: 3.616

4.  Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: recovery from a long-term-nonprogressor SIV-infected macaque.

Authors:  J Glamann; D R Burton; P W Parren; H J Ditzel; K A Kent; C Arnold; D Montefiori; V M Hirsch
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

5.  Vaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable to protect rhesus monkeys from SIV experimental challenge.

Authors:  K Schlienger; D C Montefiori; M Mancini; Y Rivière; P Tiollais; M L Michel
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

6.  Variation of human immunodeficiency virus type-1 reverse transcriptase within the simian immunodeficiency virus genome of RT-SHIV.

Authors:  Debra A Wadford; Robert C Kauffman; Jesse D Deere; Scott T Aoki; Richard A Stanton; Joanne Higgins; Koen K A Van Rompay; Andradi Villalobos; James H Nettles; Raymond F Schinazi; Niels C Pedersen; Thomas W North
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.